We are live on ! Find out more

LITS

Lite Strategy Inc

LITS

Market cap $37.4M

1.10 USD

+0.04

3.77%

At close Updated Sep 11, 12:48 PM EDT

1 day

3.77%

5 days

7.84%

1 month

22.06%

3 months

48.69%

6 months

-5.98%

Year to date

-28.57%

1 year

-65.3%

5 years

-98.08%

10 years

-96.89%

About: Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Employees: 4

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced that members of the Company's leadership team will present and host one-on-one investor meetings at the 28th Annual H.C.

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

SAN DIEGO, July 30, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced that since it commenced utilization of its Share Repurchase Program (the “Program”) in December 2025 and through July 17, 2026, it has repurchased approximately 4.9 million shares of its common stock, or 13% of the shares outstanding at the time the Program commenced. The Company deployed approximately $5.4 million at an average price of $1.11 per share and funded the repurchases entirely through its active treasury operations.

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced its participation in a featured panel at the Litecoin Foundation Summit, taking place June 22-23, 2026 at the Tobacco Theatre in Amsterdam, Netherlands. The Litecoin Foundation Summit is the flagship annual gathering of the Litecoin ecosystem, held this year in collaboration with Dutch Blockchain Week.

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

Lite Strategy Leads Strategic Investment in LitVM

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced the closing of a $1.0 million lead strategic investment in ZK Innovations Inc., the developer of LitVM, the first zero-knowledge (ZK) Layer 2 platform built on Litecoin. The investment reflects Lite Strategy's belief that increasing Litecoin's utility and functionality can strengthen the network and increase long-term shareholder value.

Lite Strategy Leads Strategic Investment in LitVM

Lite Strategy Reports Fiscal 2026 Third Quarter Results

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced financial results for the fiscal 2026 third quarter ended March 31, 2026. Business and Financial Highlights: Active Treasury Management: Successfully continued the Company's covered call option program, generating $0.7 million in net proceeds since October 2025 and further demonstrating Lite Strategy's ability to transform its LTC holdings into a yield-generating reserve asset and differentiate itself from passive investment vehicles.

Lite Strategy Reports Fiscal 2026 Third Quarter Results

Lite Strategy Reports Fiscal 2026 Second Quarter Results

SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced financial results for the fiscal 2026 second quarter ended December 31, 2025. During the second quarter, the Company successfully launched its strategic initiative to transform its LTC holdings into a productive reserve asset, utilizing covered call options while also implementing a $25 million stock repurchase program.

Lite Strategy Reports Fiscal 2026 Second Quarter Results

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or the “Company”) today announced that it will change its corporate name to Lite Strategy, Inc., reflecting the Company's expansion into a pioneer in digital asset treasury management. Alongside the rebrand, the Company's ticker symbol on the NASDAQ Stock Market will transition from MEIP to LITS, effective at market open on September 11, 2025. The rebranding to Lite Strategy, Inc. underscores the Company's commitment to building.

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launching a major institutional treasury strategy with the LTC treasury now valued at approximately $110.4 million as of August 4, 2025. MEI becomes the first U.S.-listed public company to adopt Litecoin as a primary reserve asset, implementing a new strategy built on digital asset infrastructure and lo.

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

[UK, July 24, 2025] - BTC As the blockchain industry enters a new round of market cycle, the multi-currency linkage effect gradually emerges, and the price of BTC today starts to rise at 118875.30. According to foreign media reports such as Investing, with the continuous inflow of US spot ETF funds, the acceleration of technology implementation by the Ethereum Layer 2 Industry Alliance, and the launch of the network upgrade of Dogecoin (DOGE), Bitcoin's "safe-haven attribute" as a market value anchor has once again attracted capital favor, and its network computing power and BTC mining income have increased significantly. Another major positive news this week also boosted BTC confidence: MEI Pharmaceuticals (NASDAQ: MEIP) announced that Litecoin (LTC) will be included in the corporate treasury portfolio and completed the allocation of digital assets worth $100 million, which has aroused the capital market's deep attention to the reserve allocation model of encrypted assets. This behavior not only verifies the trust of mainstream institutions in encrypted assets, but also indirectly drives the prices of major currencies including Bitcoin to rise simultaneously. Hashj made timely adjustments to the market and provided new members with a maximum registration reward of $118 for BTC mining experience.

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy.

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

See News Rankings

Price charts implemented using Lightweight Charts™